Company Filing History:
Years Active: 2011-2017
Title: Innovations of Shuji Mori in Neutrophil Activation Regulation
Introduction
Shuji Mori is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of medical science, particularly in the area of neutrophil activation and its implications for various diseases. With a total of 3 patents, his work focuses on therapeutic agents and methods for predicting the severity of systemic inflammatory response syndrome (SIRS).
Latest Patents
Mori's latest patents include innovative approaches to treating diseases caused by neutrophil activation. One of his key inventions is a neutrophil activation regulator that comprises a histidine-rich glycoprotein (HRG). This invention aims to provide a therapeutic agent for SIRS and other inflammatory diseases. Additionally, he has developed methods for predicting the severity of SIRS by determining the blood level of HRG in affected subjects. Another patent focuses on a treatment method and inspection method for diseases caused by neutrophil activation, emphasizing the importance of HRG as an active ingredient.
Career Highlights
Throughout his career, Shuji Mori has been associated with reputable institutions such as Okayama University and Sowakai Medical Foundation. His work has been instrumental in advancing the understanding of neutrophil-related diseases and developing effective treatment strategies.
Collaborations
Mori has collaborated with notable colleagues, including Masahiro Nishibori and Hideo Takahashi. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Shuji Mori's innovative work in the field of neutrophil activation regulation has the potential to significantly impact the treatment of inflammatory diseases. His contributions through patents and collaborations highlight the importance of continued research in this area.